bioRxivCancer Biology
Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome.
S. H. Strand, K. E. Houlahan, V. Branch, T. Lynch, B. Harmon, F. Couch, K. Gallagher, M. Kilgore, S. Wei, A. DeMichele, T. King, P. McAuliffe, C. Curtis, K. Owzar, J. R. Marks, G. A. Colditz, E. S. Hwang, R. B. West
Abstract
Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive breast cancer (IBC). Studies have indicated differences in DCIS outcome based on race or ethnicity, but molecular differences have not been investigated. We examined the molecular profile of DCIS by self-reported race (SRR) and outcome groups in Black (n=99) and White (n=191) women with DCIS in a large DCIS case-control cohort with longitudinal follow up. Gene expression and pathway analyses indicated that different genes and pathways are involved in ipsilateral breast outcome (DCIS or IBC) after DCIS treatment in White versus Black women. We identified differences in ER and HER2 expression, tumor microenvironment composition, and copy number variations by SRR and outcome groups. Our results suggest that different molecular mechanisms drive subsequent ipsilateral breast events in Black versus White women.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The impact of patient biology on racial disparities in breast cancer outcome
Jerry Tyler DeWitt, D Jimenez-Tovar, … Svasti Haricharan·Cancer ResearchPeer-reviewed·Oct 26, 2026
- The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ
Daniela Nachmanson, Adam Officer, … Olivier Harismendy·npj Breast CancerPeer-reviewed·Jan 13, 2022
- DCIS genomic signatures define biology and clinical outcome: Human Tumor Atlas Network (HTAN) analysis of TBCRC 038 and RAHBT cohorts
S. H. Strand, B. Rivero-Gutierrez, … K Owzar·bioRxiv·Jun 16, 2021
- Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy
Noor Rizvi, Eliseos J. Mucaki, … Vanessa Dumeaux·Breast Cancer ResearchPeer-reviewed·Jul 8, 2025
- A Single-Cell Peripheral Immune Atlas Spanning High-Risk Lesions to Invasive Breast Cancer in Black and White Women
Fangyuan Chen, Esther Ritah Ogayo, … Sandra S. McAllister·bioRxiv·May 7, 2026
- Investigating racial disparities in carcinomas through TCGA transcriptomic and proteomic database
Brian Lei, Xinyin Jiang, Anjana D. Saxena·CancersPeer-reviewed·May 10, 2023